Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 976-993

  Yang, Yi Ping ^a   Chang, Yuh Lih ^a   Huang, Pin I ^a   Chiou, Guang Yuh ^a   Tseng, Ling Ming ^a   Chiou, Shih Hwa ^a   Chen, Ming Hsiung ^a   Chen, Ming Teh ^a   Shih, Yang Hsin ^a   Chang, Chin Hong ^b   Hsu, Chuan Chih ^b   Ma, Hsin I ^c   Wang, Chin Tien ^a   Tsai, Lo Lin ^d,e   Yu, Cheng Chia ^d,e   Chang, Charn Jung ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; RESVERATROL; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTROCYTOMA; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MICE; MICE, SCID; MIDDLE AGED; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STILBENES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84155184247     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22806     Document Type: Article

References (48)

1. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H. 2006. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: Modern target but ancient solution. Ann NY Acad Sci 1091: 151-169.
2. Altaner C. 2008. Glioblastoma and stem cells. Neoplasma 55: 369-374.
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
4. Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB. 2007. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109: 2293-2302.
5. Bowman T, Garcia R, Turkson J, Jove R. 2000. STATs in oncogenesis. Oncogene 19: 2474-2488.
6. Bradamante S, Barenghi L, Villa A. 2004. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188.
7. Brantley EC, Benveniste EN. 2008. Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas. Mol Cancer Res 6: 675-684.
8. Bromberg JF. 2001. Activation of STAT proteins and growth control. Bioessays 23: 161-169.
9. Bromberg J. 2002. Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142.
10. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. 2003. Resveratrol and cancer: Chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anticancer Agents 3: 77-93.
11. Chang CJ, Hsu CC, Yung MC, Chen KY, Tzao C, Wu WF, Chou HY, Lee YY, Lu KH, Chiou SH, Ma HI. 2009. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun 380: 236-242.
12. Chautard E, Loubeau G, Tchirkov A, Chassagne J, Vermot-Desroches C, Morel L, Verrelle P. 2010. Akt signaling pathway: A target for radiosensitizing human malignant glioma. Neurooncology 12: 434-443.
13. Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT, Wong TT. 2008a. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE 3: e2090.
14. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF. 2008b. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
15. Chiou SH, Chen SJ, Chang YL, Chen YC, Li HY, Chen DT, Wang HH, Chang CM, Chen YJ, Ku HH. 2010. MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin-positive cells. J Cell Mol Med 15: 612-624.
16. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. 2007. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17: 165-172.
17. Das S, Das DK. 2007. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6: 168-173.
18. de la Lastra CA, Villegas I. 2005. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49: 405-430.
19. Dehdashti AR, Hegi ME, Regli L, Pica A, Stupp R. 2006. New trends in the medical management of glioblastoma multiforme: The role of temozolomide chemotherapy. Neurosurg Focus 20: E6.
20. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R, Loughran TP, Jr. 2001. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107: 351-362.
21. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG. 2010. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28: 5-16.
22. Gao L, Li F, Dong B, Zhang J, Rao Y, Cong Y, Mao B, Chen X. 2010. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int J Radiat Oncol Biol Phys 77: 1223-1231.
23. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. 2003. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183.
24. Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T. 2008. Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 25: 67-72.
25. Kao CL, Huang PI, Tsai PH, Tsai ML, Lo JF, Lee YY, Chen YJ, Chen YW, Chiou SH. 2009. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys 74: 219-228.
26. Knizetova P, Darling JL, Bartek J. 2008. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. J Cell Mol Med 12: 111-125.
27. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R. 2006. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5: 621-629.
28. Kundu JK, Surh YJ. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 269: 243-261.
29. Lee JT, Herlyn M. 2007. Old disease, new culprit: Tumor stem cells in cancer. J Cell Physiol 213: 603-609.
30. Li GH, Wei H, Chen ZT, Lv SQ, Yin CL, Wang DL. 2009. STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251cells. J Neurooncol 91: 165-174.
31. Liao HF, Kuo CD, Yang YC, Lin CP, Tai HC, Chen YY, Chen YJ. 2005. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res (Tokyo) 46: 387-393.
32. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, Chien CS, Tseng LM, Chu PY, Lu KH, Chang KW, Kao SY, Chiou SH. 2011. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223: 482-495.
33. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. 2007. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32: 981-987.
34. Nguyen HG, Ravid K. 2006. Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol 208: 12-22.
35. Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Fujioka T, Tanji S, Mo YY, Cao D, Wilber AC, Watabe K. 2010. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat [Epub ahead of print].
36. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ. 2002. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21: 8404-8413.
37. Reynolds BA, Rietze RL. 2005. Neural stem cells and neurosphere-Re-evaluating the relationship. Nat Methods 2: 333-336.
38. Senft C, Priester M, Polacin M, Schroder K, Seifert V, Kogel D, Weissenberger J. 2011. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403.
39. Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK. 2011. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and kras transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS ONE 6: e16530.
40. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
41. Villalva C, Martin-Lanneree S, Cortes U, Dkhissi F, Wager M, Le Corf A, Tourani JM, Dusanter-Fourt I, Turhan AG, Karayan-Tapon L. 2011. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? Int J Cancer 128: 826-838.
42. Wang H, Lathia JD, Wu Q, Wang J, Li Z, Heddleston JM, Eyler CE, Elderbroom J, Gallagher J, Schuschu J, MacSwords J, Cao Y, McLendon RE, Wang XF, Hjelmeland AB, Rich JN. 2009. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27: 2393-2404.
43. Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF, Yu CC. 2010. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer 9: 283.
44. Yu H, Jove R. 2004. The STATs of cancer-New molecular targets come of age. Nat Rev Cancer 4: 97-105.
45. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY, Liu J. 2008. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10: 736-744.
46. Yu CC, Chiou GY, Lee YY, Chang YL, Huang PI, Cheng YW, Tai LK, Ku HH, Chiou SH, Wong TT. 2010. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity. Childs Nerv Syst 26: 897-904.
47. Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS, Tseng LM, Hung SC, Kao SY, Chang CJ, Chiou SH. 2011. Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol 2011.
48. Zou GM. 2008. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 217: 598-604.